Ncahojs2tqqdzkcqtg03 logoncodesign vert 4 1 2013 3 1

Oncodesign

3 Orders Completed
Dijon, FR

About Oncodesign

Founded: 1995 Type: Public Company Size: 51-200 employees

**Breaking new : Oncodesign offers assessment solutions to evaluate innovative preventive and therapeutic strategies for COVID-19 (sars-CoV-2). Click 'Request More Info' button on this page to ask about offer details.**


SOLUTION PROVIDER ACROSS MAJOR THERAPEUTIC AREAS


Oncodesign is a leading biopharmaceutical company that meets the needs of innovation in the health industry through precision medicine. The company has built an industrial model of innovation to orientate new therapeutic molecules to fight serious illnesses with unmet medical needs : cancer, immuno-oncology, immunology, inflammation and infectious diseases.

 

Starting out from your targets or your molecules, we orient, drive and perform discovery or development programs to select the best drug candidates thanks to our following services:

 

  • IDDS (Integrated Drug Discovery Services) – DRIVE

From target validation to preclinical candidate and IND


  • DDSA (Discovery and Development  Strategic Alliance)

Strategic discovery program management up to clinical phase


  • Stand-alone services (fee-for-service)

          Proof of concept – Pharmacology

          Pharmaco imaging

          Targeted radiotherapy

          ADME/DMPK

          Bioanalysis

          Biopharmaceutical products services

          Biodecontamination/Biosafety

          Biobanking

 

WHAT CAN YOU EXPECT FROM ONCODESIGN?

 

Oncodesign recognizes it is a significant investment for clients to select and access specialized technologies and expert scientist resources with an extensive knowledge of pharmaceutical drug discovery and development. When it comes to outsourcing client projects, quality, innovation, time and agility are key components for clients seeking to build a trusted and long-term relationship.

 

Helping our clients identify new approaches and anticipate tomorrow’s challenge

Oncodesign is a vector for therapeutic innovation. As such, for over two decades, Oncodesign has invested in a continuum of technologies platforms (Predict®, Xmice®, T.O.T.®, OncoSNIPE® and Pharmimage®) to support Precision Medicine innovation model. These platforms come from the technological specificities of the company, thanks to a mesh pattern of scientific skills, knowledge & know-how and innovative technologies.


Thanks to these platforms we support our clients investigating and establishing preclinical proof-of concept of a multitude of therapeutic approaches and products.
So far, 5,000 advanced preclinical or clinical therapeutic solutions have been assess ranging from new chemical entities, biologics, cell or gene therapy, systemic targeted radiotherapies as well as combination therapies.


A strong track record

Oncodesign’s multidisciplinary research teams and our seasoned management staff have had true accomplishments in drug discovery, having delivered more than 20 pre-clinical candidates to clients, partners and internally. A significant number of pre-clinical candidates, including first-in-class, have already progressed into clinical trials


Besides, we have been serving more than 800 clients amongst pharmaceutical, biotech and life-science companies around the world to assess numerous treatment options in preclinical proof-of-concept studies across major therapeutic areas.

We also take pride in the trust and fidelity of our clients proven by long term agreements and sustained repeat business.


Mutual understanding & customized project management

We first listen to and understand clients’ requirements to design their tailored studies or discovery programs. Together, we set key milestones to reach endpoints such as activity, selectivity, pharmacological or ADME profile and toxicity, within a defined frame time.

To allow our client to take informed and on-time decisions, we implement program or project management to insure constructive and regular discussions.


A collaborative mindset from a team with mix of backgrounds, experiences & skills

For Oncodesign "we must succeed together". The creation of value arising from reciprocity, that is to say balanced, and transparent exchanges at all levels, with our partners, our clients.


We acknowledge the diversity of our clients’ cultures and needs. However, all clients seek our team ability to design and perform studies or discovery programs encompass highest pharmaceutical standard to deliver robust data and products. Oncodesign combines a biotechnology mindset to seek for all fast track pathways along with a sense of service to deliver and communicate on purpose.


Our management, scientific and business development teams encompass a mix of origin, experiences and skills. This diversity is a valuable asset to Oncodesign, allowing us to understand each unique client and to drive discovery programs knowing that no two projects will ever be the same.


Quality meeting client satisfaction & regulatory requirements

Oncodesign’s quality management aims to set-up a framework to monitor our ability to meet client satisfaction in drug discovery and development along with regulatory requirements.


We drive our quality management process in a continuous improvement approach, as part of the comprehensive company management. As such, Oncodesign welcomes inspections and audits from clients & health authorities for the work being considered.


Furthermore, for non-clinical development, Oncodesign is GLP compliant with grade A certification from French authorities (ANSM).


Our Services (68)


ic

Integrated Drug Discovery

Price on request

DRIVE™ (DRug Integrative discoVEry): an integrated drug discovery and development solution from hit finding to IND filing.


The drug discovery process is faced with a growing pressure to deliver novel therapeutic agents faster and with a potential for a lower attrition in the clinic, to treat diseases with high unmet medical needs. For the past 25 years, Oncodesign has been building an integrated drug discovery engine for precision medicine enabling to orient, drive the discovery and deliver pre-clinical candidates successfully.


DRIVE™ is part of our continuous improvement in the integrated drug discovery support. It gives access to a comprehensive continuum of technological platforms together with our strategic partners’ complementary expertise. DRIVE™ is a smart and agile solution to help clients streamline their drug discovery and development programs and to make best use of their resources and achieve optimum results.


DRIVE™ offers a complete drug discovery and development solution through the whole value chain from hit finding to IND filing, aiming to accelerate the entry of the client new chemical entities into clinic within a 3 to 4 years timeframe to deliver an IND.



Our distinctiveness comes from our expertise in the breadth and depth of innovative service


DRIVE™ encompasses all drug discovery skills, expertise and platforms to deliver drug in major therapeutic areas, such as oncology, immuno-oncology, immuno-inflammation and inflammation.


The quality of the starting hits impact the future likelihood of success to Pre-clinical candidate. Additionally, clients seek for rapid optimization and development cycles from hit finding, hit to lead and drug candidates.


DRIVE™ enables our clients with the best possible options to identify and validate promising hit series, owing to the innovative technologies provided by our strategic partners, HitGen, 2Bind and others.


DRIVE™ also, sustains the Hit to Pre-Clinical Candidate process in a Multiparametric optimization mode and with a fast streamlined testing of every newly synthesized compounds. This holds from our experienced multi-disciplinary teams in the drug discovery process, efficiently interacting to allow rapid iteration and results sharing between medicinal chemistry, in vitro and in vivo pharmacology and DMPK.

Oncology Immuno-Oncology Inflammation Target ID target validation Hit to lead Lead optimization preclinical toxicology studies Target Identification Rodents non-rodent Non-human primates (NHP) Oncology Immuno-Oncology Inflammation Show 15 more tags Show less

ic

Infectious Disease Animal Models

Price on request

Oncodesign
mission’s is to “discover innovative new therapies effective against serious
illnesses with unmet medical needs”. Within the frame of IDMIT (Infectious
Disease Models and Innovative Therapies), a national French research
infrastructure, Oncodesign offers solutions to evaluate innovative preventive
and therapeutic strategies in particular for HIV/AIDS, Coronavirus, Dengue,
Chikungunya, influenza, yellow fever, etc.


Oncodesign offers straightforward, immediately available or shortly validated in vitro & in vivo models, including imaging studies in infected Non Human Primate to assess Covid-19 infection and its associated complications, such as inflammatory or immune reactions (fibrosis, cytokine storms).


In vitro models


Biochemical assay

Spike S - ACE (protein-protein interactions)

TMPRSS2

Cell assay

Sars-Cov-2 infected cells: Human (lung, intestine, broncho-pulmonar), Monkey (kidney)


Viral load

Cytopathogenic effect

Immune modulation

Air-liquid interface


SARS-CoV-2 infected animal models


Non-Human Primate Monkey


Induction of a COVID-19-like disease
Prolonged excretion of virus from nose & throat
Pulmonary lesions characterized by CT & PET-CT

Seroconversion

Early inflammatory response

Low fever

Golden Syrian Hamster


Airways & lung inflammation with diffuse alveolar damage
Viral antigens in bronchial epithelial cells, pneumocytes, alveolar macrophages
Clinical manifestations associated with weight loss peaking
Lymphoid atrophy associated with marked innate immune cell activation
Neutralizing Abs detection



Additional models associated to Covid-19 complications

COVID-19 patients may progress to Acute Respiratory Distress Syndrome (ARDS), of which a subset of survivors will develops lung fibrosis. Within, this frame, Oncodesign has a validated Bleomycin induced pulmonary fibrosis model in C57BL/6 mice.

Additionally, early research indicate that many of the fatal cases of COVID-19 result from over-activation of a person’s immune system, referred to as a “cytokine storm”, could be key in preventing the virus deadly effects.

To investigate number of strategies, both repurposing and new ones, Oncodesign can assess the reduction of activation of immune cells by assessing cytokine production or specific signaling pathways dependent on pro-inflammatory cytokines.


Discover our offer

COVID-19 Infectious Disease Dengue virus infection HIV Chikungunya virus infection Animal models of infection Zika virus infection in vitro in vivo Rodents Non-human primates (NHP) Show 11 more tags Show less

ic

Patient-Derived Xenograft (PDX)

Price on request

We are also focusing our efforts to provide potentially more predictive models. Oncodesign's Chi-Mice® technological platform consists of:
Reconstituted human immune system models
Patient-derived xenografts (PDX) in immunodeficient mice and rats
PDX combined with human immune system models
Specific model development via our international biological resource collection network


ic

Lung Patient Derived Xenograft (PDX)

Price on request
Request a quote for more information about this service.

ic

Colon Patient Derived Xenograft (PDX)

Price on request
Request a quote for more information about this service.

ic

Breast Patient Derived Xenograft (PDX)

Price on request
Request a quote for more information about this service.

ic

Bladder Patient Derived Xenograft (PDX)

Price on request
Request a quote for more information about this service.

ic

Cytotoxicity Assays

Price on request
Request a quote for more information about this service.

ic

Leukemia Animal Models

Price on request
Request a quote for more information about this service.

ic

Skin Graft Animal Models

Price on request
Request a quote for more information about this service.

ic

Multidrug Resistance (MDR) Testing

Price on request
Request a quote for more information about this service.

ic

Drug Target Identification

Price on request
Request a quote for more information about this service.

ic

ADCC and CDC Assays

Price on request
Request a quote for more information about this service.

ic

Bone Metastasis Animal Models

Price on request
Request a quote for more information about this service.

ic

Human Tumor Xenograft Models

Price on request
Request a quote for more information about this service.

ic

Genetically Engineered Mice

Price on request
Request a quote for more information about this service.

ic

ADME/DMPK Studies

Drug Metabolism and Pharmacokinetics
Price on request
Request a quote for more information about this service.

ic

Surgical Animal Models

Price on request
Request a quote for more information about this service.

ic

Custom Cell-Based Assay Development

Price on request
Request a quote for more information about this service.

ic

Assay Development Consulting

Price on request
Request a quote for more information about this service.

ic

Radiolabeling/Radiosynthesis

Price on request
Request a quote for more information about this service.

ic

Custom Oncology Animal Models

Price on request
Request a quote for more information about this service.

ic

Orthotopic Tumor Animal Models

Price on request
Request a quote for more information about this service.

ic

Compound Profiling in Cancer Cell Panels

Price on request
Request a quote for more information about this service.

ic

Custom Animal Models

Price on request
Request a quote for more information about this service.

ic

Pharmaco-Imaging

Price on request
Request a quote for more information about this service.

ic

Animal Model in vivo Analyses

Price on request
Request a quote for more information about this service.

ic

In vitro Oncology Models

Price on request
Request a quote for more information about this service.

ic

Imaging Technology Platforms

Price on request
Request a quote for more information about this service.

ic

Hematopoiesis

Price on request
Request a quote for more information about this service.

ic

Metastatic Tumor Animal Models

Price on request
Request a quote for more information about this service.

ic

In vivo Drug Efficacy Testing

Price on request
Request a quote for more information about this service.

ic

Custom Hematology Animal Models

Price on request
Request a quote for more information about this service.

ic

Genetic Engineering

Price on request
Request a quote for more information about this service.

ic

Oncology Animal Models

Price on request
Request a quote for more information about this service.

ic

Animal Models and Studies

Price on request
Request a quote for more information about this service.

ic

Medical Imaging Services

Price on request
Request a quote for more information about this service.

ic

Transgenic Mouse Services

Price on request
Request a quote for more information about this service.

ic

Toxicology

Price on request
Request a quote for more information about this service.

ic

Drug Discovery

Price on request
Request a quote for more information about this service.
Oncology Immuno-Oncology Inflammation integrated drug discovery Target ID target validation Hit to lead Lead optimization preclinical toxicology studies Rodents Non-human primates (NHP) non-rodent Show 12 more tags Show less

ic

Cells and Tissues

Price on request
Request a quote for more information about this service.

ic

Radiochemistry

Price on request
Request a quote for more information about this service.

ic

Cell-Based Assays

Price on request
Request a quote for more information about this service.

ic

Dermatology Animal Models

Price on request
Request a quote for more information about this service.

ic

Clinical Microbiology, Virology and Parasitology

Price on request
Request a quote for more information about this service.

ic

Biology

Price on request
Request a quote for more information about this service.

ic

Clinical Research

Price on request
Request a quote for more information about this service.

ic

Clinical Laboratory Services

Price on request
Request a quote for more information about this service.

ic

Transgenic Animal Model Development

Price on request
Request a quote for more information about this service.

ic

Drug Discovery & Development

Price on request
Request a quote for more information about this service.

ic

Process Consulting

Price on request
Request a quote for more information about this service.

ic

Animal Models of Disease

Price on request
Request a quote for more information about this service.

ic

In vitro Disease Models

Price on request
Request a quote for more information about this service.

ic

Hematology Animal Models

Price on request
Request a quote for more information about this service.

ic

Imaging & Spectroscopy

Price on request
Request a quote for more information about this service.

ic

Pharmacology & Toxicology

Price on request
Request a quote for more information about this service.

ic

Xenograft Models

Price on request
Request a quote for more information about this service.

ic

Lead Identification and Validation

Price on request
Request a quote for more information about this service.

ic

Chemistry and Materials

Price on request
Request a quote for more information about this service.

ic

Project Management

Price on request
Request a quote for more information about this service.

ic

Specialized Cell-Based Assays

Price on request
Request a quote for more information about this service.

ic

In vivo Pharmacology Studies

Price on request

In vivo Pharmacology Studies Services


ic

Pharmacology

Price on request

Pharmacology Services


ic

Assay Development

Price on request
Request a quote for more information about this service.

ic

Rare Disease Animal Models

Price on request
Request a quote for more information about this service.

ic

In vitro Neurodegeneration Models

Price on request
Request a quote for more information about this service.

ic

In vitro Inflammation Models

Price on request
Request a quote for more information about this service.

ic

MALDI Tissue Imaging

Matrix-Assisted Laser Desorption Ionization Tissue Imaging
Price on request
Request a quote for more information about this service.

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.

FileType/PDF Created with Sketch. Elevator_Pitch_Oncodesign_FinalVersion.pdf

Click to Download

FileType/PDF Created with Sketch. oncodesign-depliant-corpo-0002D-print-interne.pdf

Click to Download

FileType/PDF Created with Sketch. oncodesign-IDDS.pdf

Click to Download

FileType/PDF Created with Sketch. oncodesign-Partnering.pdf

Click to Download

FileType/PDF Created with Sketch. oncodesign-Service.pdf

Click to Download
  • Positive review for Orthotopic Tumor Animal Models:

    April 2018

    "Hi there, I will use their services again, as it works really well with the progress updates and the services in general. I am in favor of the principles of the system. However, as a local site we have local processes for the generation of for instance our PO numbers and local payment details and it is important for us to have these details included when finalizing orders to avoid additional complications, and to obey to the local compliance requirements. Thanks, Mia"

Oncodesign has not received any endorsements.